title: Glial reactivity and impaired glutamate metabolism in short-term experimental diabetic retinopathy. Penn State Retina Research Group.
abstract: The early pathophysiology of diabetic retinopathy and the involvement of neural and vascular malfunction are poorly understood. Glial cells provide structural and metabolic support for retinal neurons and blood vessels, and the cells become reactive in certain injury states. We therefore used the streptozotocin rat model of short-term diabetic retinopathy to study glial reactivity and other glial functions in the retina in the first months after onset of diabetes. With a two-site enzyme-linked immunosorbent assay, we measured the expression of the intermediate filament glial fibrillary acidic protein (GFAP). After 1 month, GFAP was largely unchanged, but within 3 months of the beginning of diabetes, it was markedly induced, by fivefold (P < 0.04). Immunohistochemical staining showed that the GFAP induction occurred both in astrocytes and in Müller cells. Consistent with a glial cell malfunction, the ability of retinas to convert glutamate into glutamine, assayed chromatographically with an isotopic method, was reduced in diabetic rats to 65% of controls (P < 0.01). Furthermore, retinal glutamate, as determined by luminometry, increased by 1.6-fold (P < 0.04) after 3 months of diabetes. Taken together, these findings indicate that glial reactivity and altered glial glutamate metabolism are early pathogenic events that may lead to elevated retinal glutamate during diabetes. These data are the first demonstration of a specific defect in glial cell metabolism in the retina during diabetes. These findings suggest a novel understanding of the mechanism of neural degeneration in the retina during diabetes, involving early and possibly persistent glutamate excitotoxicity.
authors.affiliation: Department of Neuroscience and Anatomy, Pennsylvania State University College of Medicine, Hershey Medical Center, 17033, USA. lieth@psu.edu
authors.forename: E
authors.initials: E
authors.lastname: Lieth
authors.forename: A J
authors.initials: AJ
authors.lastname: Barber
authors.forename: B
authors.initials: B
authors.lastname: Xu
authors.forename: C
authors.initials: C
authors.lastname: Dice
authors.forename: M J
authors.initials: MJ
authors.lastname: Ratz
authors.forename: D
authors.initials: D
authors.lastname: Tanase
authors.forename: J M
authors.initials: JM
authors.lastname: Strother
mesh_terms: D000208:Acute Disease; D000818:Animals; D003921:Diabetes Mellitus, Experimental / Q000503:physiopathology*; D003930:Diabetic Retinopathy / Q000139:chemically induced / Q000503:physiopathology*; D004797:Enzyme-Linked Immunosorbent Assay; D005904:Glial Fibrillary Acidic Protein / Q000032:analysis; D018698:Glutamic Acid / Q000378:metabolism*; D015151:Immunoblotting; D007150:Immunohistochemistry; D009457:Neuroglia / Q000502:physiology*; D051381:Rats; D017207:Rats, Sprague-Dawley; D012160:Retina / Q000378:metabolism*
chemical_list: D005904:Glial Fibrillary Acidic Protein; D018698:Glutamic Acid